These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38538321)

  • 21. Identification and immuno-infiltration analysis of cuproptosis regulators in human spermatogenic dysfunction.
    Zhao M; Yu WX; Liu SJ; Deng YJ; Zhao ZW; Guo J; Gao QH
    Front Genet; 2023; 14():1115669. PubMed ID: 37065492
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and validation of potential diagnostic signature and immune cell infiltration for HIRI based on cuproptosis-related genes through bioinformatics analysis and machine learning.
    Xiao F; Huang G; Yuan G; Li S; Wang Y; Tan Z; Liu Z; Tomlinson S; He S; Ouyang G; Zeng Y
    Front Immunol; 2024; 15():1372441. PubMed ID: 38690269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
    Tian X; Zhu S; Liu W; Wu X; Wei G; Zhang J; Anwaier A; Chen C; Ye S; Che X; Xu W; Qu Y; Zhang H; Ye D
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17451-17466. PubMed ID: 37889309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression.
    Wang W; Chen Z; Hua Y
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel cuproptosis-related prognostic gene profiles in preeclampsia.
    Tang X; Liu Y; Zhang Y
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):53. PubMed ID: 38200445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
    Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
    Li Y; Zeng X
    Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
    [No Abstract]   [Full Text] [Related]  

  • 28. Cuproptosis-related Gene Signatures and Immunological Characterization in Sepsis-associated Acute Lung Injury.
    Zhu M; Tang X; Xu J; Gong Y
    Comb Chem High Throughput Screen; 2024 May; ():. PubMed ID: 38779731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
    Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
    Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease.
    Shi X; Pan Z; Cai W; Zhang Y; Duo J; Liu R; Cai T
    Front Immunol; 2023; 14():1171445. PubMed ID: 37266442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress.
    Chang B; Hu Z; Chen L; Jin Z; Yang Y
    Front Immunol; 2023; 14():1090596. PubMed ID: 36817415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia.
    Zhu Y; Chen X; Geng S; Li Q; Li Y; Yuan H; Jiang H
    Front Genet; 2023; 14():1136763. PubMed ID: 37007946
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis.
    Zhu Y; Chang S; Liu J; Wang B
    Immun Inflamm Dis; 2023 Nov; 11(11):e1058. PubMed ID: 38018590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of cuproptosis-related genes in acetaminophen-induced liver injury using bioinformatics analysis and machine learning.
    Guo Z; Liu J; Liang G; Liang H; Zhong M; Tomlinson S; He S; Ouyang G; Yuan G
    Front Immunol; 2024; 15():1371446. PubMed ID: 38994365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immunological characteristics and cuproptosis-related molecular clusters in primary Sjögren's syndrome.
    Wei B; Wang A; Liu W; Yue Q; Fan Y; Xue B; Wang S
    Int Immunopharmacol; 2024 Jan; 126():111251. PubMed ID: 37984252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
    Chen Y
    Front Genet; 2022; 13():912037. PubMed ID: 35937995
    [No Abstract]   [Full Text] [Related]  

  • 39. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
    Wang S; Xing N; Meng X; Xiang L; Zhang Y
    Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction.
    Liu Z; Wang L; Xing Q; Liu X; Hu Y; Li W; Yan Q; Liu R; Huang N
    Front Cardiovasc Med; 2022; 9():1016081. PubMed ID: 36440046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.